ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Diagnosing Inherited Platelet Disorders: Immunofluorescence on the Blood Smear in Comparison with Genetic Testing

C. Zaninetti1,2, J. Rivera3, E. Leinøe4, E. Zetterberg5, J.M. Bastida6, M. Rossing7, M. Wolff1, C. Freyer1, A. Greinacher1

1Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany, 2University of Pavia, Pavia, Italy, 3Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Murcia, Spain, 4Department of Haematology, Copenhagen University Hospital, Copenhagen, Denmark, 5Department of Haematology, Oncology and Radiation Physics, Coagulation Unit, Skane University Hospital, Malmö, Sweden, 6Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain, 7Centre for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Abstract Number: OC 21.1

Meeting: ISTH 2021 Congress

Theme: Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » Inherited Thrombocytopenias

Background: Inherited platelet disorders (IPDs) are characterized by reduced or dysfunctional platelets. Diagnostic tools include clinical evaluation, functional tests and genetic analysis. We established a diagnostic method on the blood smear by immunofluorescence microscopy.  

Aims: To compare the outcomes of immunofluorescence with those of genetic testing in a cohort of patients with suspected IPD.

Methods: Four Institutes from Greifswald, Germany, Murcia, Spain, Copenhagen, Denmark, and Malmö, Sweden, participated in the study. Subjects were enrolled from January 2019 to December 2020 by Centers of Murcia, Copenhagen and Malmö, to whom they were referred for genetic investigation. Blood smears were centralized in Greifswald and blindly analyzed. Morphologic changes were reported and potential diagnoses formulated. Subsequently, genetic results were unblinded and the comparison performed. Patients or their legal guardians signed written informed consent.

Results: 94 subjects of 70 pedigrees were enrolled. Microscopic analysis identified alterations suggestive for a specific IPD in 50 cases (53%). In 39 (42%) abnormalities not typical for known IPDs were reported and in 5 (5%) no alterations were found.
Genetic testing diagnosed a specific IPD in 42 pedigrees (60%). In total, 20 different IPDs were identified. Among these, 11 were identified by immunofluorescence based on known specific phenotypic changes. In 3 forms we identified previously unknown phenotypes, while in 6 immunofluorescence did not allow a specific diagnosis. (Table)
In 19 pedigrees (27%) variants of unknown significance (VUS) were found. Among them, in 7 (37%) immunofluorescence found phenotypic changes typical for pathogenic variants. In 9 pedigrees (13%) no variants were found. Among them, in 8 (89%) immunofluorescence found phenotypic changes in platelet structures (e.g. cytoskeleton or granules).  
Outcome of immunofluorescence (IF) assessment on the blood smear in the 42 pedigrees who received a defined molecular diagnosis of inherited platelet disorder (IPD). #based on previously reported diagnostic patterns; *previously unreported diagnostic patterns.

Conclusions: Immunofluorescence on the blood smear is an effective diagnostic tool for a substantial group of IPDs. It can help VUS interpretation and provide clinicians with information about changes in platelet structures that may account for bleeding phenotype.

To cite this abstract in AMA style:

Zaninetti C, Rivera J, Leinøe E, Zetterberg E, Bastida JM, Rossing M, Wolff M, Freyer C, Greinacher A. Diagnosing Inherited Platelet Disorders: Immunofluorescence on the Blood Smear in Comparison with Genetic Testing [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/diagnosing-inherited-platelet-disorders-immunofluorescence-on-the-blood-smear-in-comparison-with-genetic-testing/. Accessed October 2, 2023.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/diagnosing-inherited-platelet-disorders-immunofluorescence-on-the-blood-smear-in-comparison-with-genetic-testing/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley